X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (275) 275
index medicus (214) 214
secondary hyperparathyroidism (174) 174
male (154) 154
female (148) 148
hyperparathyroidism, secondary - drug therapy (141) 141
urology & nephrology (140) 140
cinacalcet hydrochloride (134) 134
cinacalcet (132) 132
middle aged (130) 130
hyperparathyroidism (127) 127
parathyroid hormone (125) 125
calcimimetic agents - therapeutic use (120) 120
parathyroid hormone - blood (119) 119
naphthalenes - therapeutic use (103) 103
calcium - blood (96) 96
adult (91) 91
aged (91) 91
hyperparathyroidism, secondary - etiology (87) 87
calcimimetics (86) 86
calcium-sensing receptor (79) 79
treatment outcome (77) 77
hemodialysis (76) 76
hemodialysis-patients (75) 75
vitamin d (72) 72
calcium (71) 71
chronic kidney-disease (68) 68
hyperparathyroidism, secondary - blood (67) 67
kidney failure, chronic - complications (65) 65
parathyroidectomy (62) 62
renal dialysis (59) 59
dialysis (58) 58
parathyroid-hormone (55) 55
chronic kidney disease (53) 53
nephrology (52) 52
renal dialysis - adverse effects (52) 52
calcimimetic agents - adverse effects (51) 51
kidney failure, chronic - therapy (49) 49
medicine & public health (49) 49
pharmacology & pharmacy (49) 49
calcimimetic (48) 48
cinacalcet hydrochloride - therapeutic use (46) 46
mineral metabolism (45) 45
naphthalenes - adverse effects (45) 45
mortality (43) 43
phosphorus - blood (41) 41
calcimimetic agent (38) 38
vascular calcification (38) 38
vitamin d - therapeutic use (36) 36
phosphorus (35) 35
stage renal-disease (35) 35
biomarkers - blood (34) 34
hypercalcemia (34) 34
naphthalenes - administration & dosage (34) 34
calcimimetic agents - administration & dosage (33) 33
dialysis patients (33) 33
disease (32) 32
hyperparathyroidism - drug therapy (32) 32
vitamin-d (32) 32
cardiovascular-disease (31) 31
care and treatment (31) 31
prospective studies (31) 31
renal insufficiency, chronic - complications (31) 31
time factors (31) 31
animals (30) 30
renal insufficiency, chronic - therapy (30) 30
kidney diseases (29) 29
risk factors (29) 29
surgery (29) 29
parathyroid-hormone levels (28) 28
retrospective studies (28) 28
chronic kidney failure (27) 27
transplantation (27) 27
hcl (26) 26
internal medicine (26) 26
kidney transplantation (26) 26
patients receiving hemodialysis (26) 26
therapy (26) 26
calcification (25) 25
endocrinology & metabolism (25) 25
hypercalcemia - drug therapy (25) 25
aged, 80 and over (24) 24
calcium - metabolism (24) 24
drug therapy (24) 24
calcimimetic amg-073 (23) 23
hypercalcemia - etiology (23) 23
chronic-renal-failure (22) 22
cinacalcet hcl (22) 22
mortality risk (22) 22
parathyroid (22) 22
dose vitamin-d (21) 21
double-blind method (21) 21
hyperparathyroidism, secondary - metabolism (21) 21
kidney transplantation - adverse effects (21) 21
analysis (20) 20
bone (19) 19
cinacalcet hydrochloride - adverse effects (19) 19
health aspects (19) 19
metabolism (19) 19
phosphate (19) 19
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (319) 319
French (3) 3
German (1) 1
Japanese (1) 1
Polish (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 2015, Volume 10, Issue 1, pp. 98 - 109
Background and objectivesElevated parathyroid hormone levels may be associated with adverse clinical outcomes in patients on dialysis. After the introduction... 
ESRD | dialysis | MORTALITY | parathyroid hormone | PERITONEAL-DIALYSIS | hyperparathyroidism | DIALYSIS OUTCOMES | CALCIUM | CARDIOVASCULAR-DISEASE | UROLOGY & NEPHROLOGY | PARATHYROID-HORMONE | MINERAL METABOLISM | RENAL REPLACEMENT | CHRONIC KIDNEY-DISEASE | CKD | PRACTICE PATTERNS | Hyperparathyroidism, Secondary - therapy | Up-Regulation | Naphthalenes - adverse effects | Prospective Studies | Parathyroidectomy - adverse effects | Humans | Middle Aged | Male | Parathyroid Hormone - blood | Renal Insufficiency, Chronic - complications | Renal Insufficiency, Chronic - therapy | Renal Dialysis - mortality | Time Factors | Renal Insufficiency, Chronic - mortality | Adult | Female | Parathyroidectomy - mortality | Renal Insufficiency, Chronic - diagnosis | Dietary Supplements - adverse effects | Parathyroidectomy - trends | Risk Assessment | Risk Factors | Treatment Outcome | Biomarkers - blood | Calcimimetic Agents - adverse effects | Calcimimetic Agents - therapeutic use | Renal Insufficiency, Chronic - blood | Vitamin D - adverse effects | Hyperparathyroidism, Secondary - blood | Cinacalcet Hydrochloride | Hyperparathyroidism, Secondary - diagnosis | Hyperparathyroidism, Secondary - mortality | Renal Dialysis - adverse effects | Aged | Vitamin D - therapeutic use | Hyperparathyroidism, Secondary - etiology | Naphthalenes - therapeutic use | Original
Journal Article
JAMA, ISSN 0098-7484, 01/2017, Volume 317, Issue 2, pp. 156 - 164
IMPORTANCE: Secondary hyperparathyroidism contributes to extraskeletal calcification and is associated with all-cause and cardiovascular mortality. Control is... 
MEDICINE, GENERAL & INTERNAL | CALCIUM-SENSING RECEPTOR | PEPTIDE AGONIST | EVOLVE TRIAL | CARDIOVASCULAR-DISEASE | MINERAL METABOLISM | BONE | CHRONIC KIDNEY-DISEASE | AMG 416 VELCALCETIDE | FGF23 | DIALYSIS | Calcimimetic Agents - administration & dosage | Nausea - chemically induced | Cinacalcet Hydrochloride - pharmacology | Humans | Middle Aged | Calcium - administration & dosage | Male | Cinacalcet Hydrochloride - administration & dosage | Parathyroid Hormone - blood | Peptides - administration & dosage | Calcium - blood | Time Factors | Calcimimetic Agents - pharmacology | Cinacalcet Hydrochloride - adverse effects | Female | Double-Blind Method | Hyperparathyroidism, Secondary - drug therapy | Administration, Oral | Biomarkers - blood | Calcimimetic Agents - adverse effects | Peptides - pharmacology | Kidney Failure, Chronic - therapy | Hyperparathyroidism, Secondary - blood | Vomiting - chemically induced | Fibroblast Growth Factors - blood | Kidney Failure, Chronic - complications | Infusions, Intravenous | Hyperparathyroidism, Secondary - etiology | Peptides - adverse effects | Renal Dialysis | Complications and side effects | Usage | Care and treatment | Parathyroid hormone | Hemodialysis | Dosage and administration | Research | Cinacalcet | Hyperparathyroidism | Patient safety | Endocrine system | Hyperthyroidism | Clinical outcomes
Journal Article
JAMA, ISSN 0098-7484, 01/2017, Volume 317, Issue 2, pp. 146 - 155
Journal Article
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 2014, Volume 12, Issue 12, p. CD006254
Journal Article
Journal Article
Journal Article
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2015, Volume 66, Issue 6, pp. 962 - 971
Journal Article
13.